Published in Thromb Res on October 15, 1983
Use of herbal products and potential interactions in patients with cardiovascular diseases. J Am Coll Cardiol (2010) 3.77
Garlic, onions and cardiovascular risk factors. A review of the evidence from human experiments with emphasis on commercially available preparations. Br J Clin Pharmacol (1989) 1.84
Effect of garlic on cardiovascular disorders: a review. Nutr J (2002) 1.81
Antifungal activity of ajoene derived from garlic. Appl Environ Microbiol (1987) 1.80
Garlic revisited: therapeutic for the major diseases of our times? J Natl Med Assoc (1988) 1.51
Pharmacodynamic interaction of warfarin with cranberry but not with garlic in healthy subjects. Br J Pharmacol (2008) 1.27
Inhibition of microbial growth by ajoene, a sulfur-containing compound derived from garlic. Appl Environ Microbiol (1996) 1.15
Inhibition of growth of the dimorphic fungus Paracoccidioides brasiliensis by ajoene. Antimicrob Agents Chemother (1989) 1.11
In vivo activity of ajoene against rodent malaria. Antimicrob Agents Chemother (1994) 1.01
Garlic. BMJ (1991) 0.97
Ajoene, a garlic compound, inhibits protein prenylation and arterial smooth muscle cell proliferation. Br J Pharmacol (2003) 0.76
Medicinal Herbals with Antiplatelet Properties Benefit in Coronary Atherothrombotic Diseases. Thrombosis (2016) 0.75
Pharmacodynamic interaction study of Allium sativum (garlic) with cilostazol in patients with type II diabetes mellitus. Indian J Pharmacol (2011) 0.75
Allicin inhibits transient outward potassium currents in mouse ventricular myocytes. Exp Ther Med (2016) 0.75
The clinical significance and costs of herbs and food supplements used by complementary and alternative medicine for the treatment of cardiovascular diseases and hypertension. J Hum Hypertens (2015) 0.75
A Review on Platelet Activating Factor Inhibitors: Could a New Class of Potent Metal-Based Anti-Inflammatory Drugs Induce Anticancer Properties? Bioinorg Chem Appl (2017) 0.75
A wireless, remote query ammonia sensor. Sens Actuators B Chem (2001) 9.00
Race-specific HIV-1 disease-modifying effects associated with CCR5 haplotypes. Proc Natl Acad Sci U S A (1999) 3.21
Changing pattern of cutaneous tuberculosis. A prospective study. Int J Dermatol (1989) 2.25
Environmental and physiological factors affecting the succinate product ratio during carbohydrate fermentation by Actinobacillus sp. 130Z. Arch Microbiol (1997) 2.25
TIMP-1, -2, -3, and -4 in idiopathic pulmonary fibrosis. A prevailing nondegradative lung microenvironment? Am J Physiol Lung Cell Mol Physiol (2000) 2.17
Human EZF, a Krüppel-like zinc finger protein, is expressed in vascular endothelial cells and contains transcriptional activation and repression domains. J Biol Chem (1998) 2.15
1-Cys peroxiredoxin, a bifunctional enzyme with glutathione peroxidase and phospholipase A2 activities. J Biol Chem (2000) 2.00
Thy-1, a novel marker for angiogenesis upregulated by inflammatory cytokines. Circ Res (1998) 1.81
Interfacial enzymology: the secreted phospholipase A(2)-paradigm. Chem Rev (2001) 1.71
Actinobacillus succinogenes sp. nov., a novel succinic-acid-producing strain from the bovine rumen. Int J Syst Bacteriol (1999) 1.53
Cardiovascular basic helix loop helix factor 1, a novel transcriptional repressor expressed preferentially in the developing and adult cardiovascular system. J Biol Chem (2000) 1.49
Intravascular hemolysis increases atherogenicity of diet-induced hypercholesterolemia in rabbits in spite of heme oxygenase-1 gene and protein induction. Atherosclerosis (2001) 1.46
Transforming growth factor-beta 1 inhibits cytokine-mediated induction of human metalloelastase in macrophages. J Biol Chem (2000) 1.46
Biology, ecology, and biotechnological applications of anaerobic bacteria adapted to environmental stresses in temperature, pH, salinity, or substrates. Microbiol Rev (1993) 1.44
Successful treatment of antimony-resistant visceral leishmaniasis with liposomal amphotericin B (L-AmpB-LRC) in a child. Trop Doct (1995) 1.43
Role of phospholipids in transport and enzymic reactions. Adv Lipid Res (1974) 1.42
Observation of B(0)(s)-->Psi(2S)Phi and measurement of the ratio of branching fractions Beta(B(0)(s)-->Psi(2S)Phi)/Beta(B(0)(s)-->J/PsiPhi). Phys Rev Lett (2006) 1.40
Transforming growth factor-beta 1 inhibition of macrophage activation is mediated via Smad3. J Biol Chem (2000) 1.38
Reconstitution of an ATP-mediated active transport system across black lipid membranes. Nature (1969) 1.37
Intrinsic perturbing ability of alkanols in lipid bilayers. Biochim Biophys Acta (1978) 1.32
[Changes in the profile of HIV-positive patients. What has happened in the last 5 years?]. An Med Interna (2000) 1.32
Microbial utilization of electrically reduced neutral red as the sole electron donor for growth and metabolite production. Appl Environ Microbiol (1999) 1.31
Role of vitamin D in pulmonary tuberculosis. J Assoc Physicians India (1984) 1.31
Tight binding inhibitors of 85-kDa phospholipase A2 but not 14-kDa phospholipase A2 inhibit release of free arachidonate in thrombin-stimulated human platelets. J Biol Chem (1994) 1.29
Interfacial enzymology of glycerolipid hydrolases: lessons from secreted phospholipases A2. Annu Rev Biochem (1995) 1.26
Long-range order in biomembranes. Adv Lipid Res (1977) 1.25
Generation of a dominant-negative mutant of endothelial PAS domain protein 1 by deletion of a potent C-terminal transactivation domain. J Biol Chem (1999) 1.20
Vascular endothelium and atherosclerosis. Handb Exp Pharmacol (2006) 1.19
Regulation of myogenic terminal differentiation by the hairy-related transcription factor CHF2. J Biol Chem (2001) 1.19
Assessment of arterial elasticity among HIV-positive participants with high CD4 cell counts: a substudy of the INSIGHT Strategic Timing of AntiRetroviral Treatment (START) trial. HIV Med (2015) 1.17
Interfacial catalysis by phospholipase A2: determination of the interfacial kinetic rate constants. Biochemistry (1991) 1.16
Measurement of the WW + WZ production cross section using the lepton + jets final state at CDF II. Phys Rev Lett (2010) 1.12
First observation of the decay Bs0-->Ds-Ds+ and measurement of its branching ratio. Phys Rev Lett (2008) 1.11
A case of scrub typhus probably acquired in Africa. Clin Infect Dis (1997) 1.11
Inhibition of growth of the dimorphic fungus Paracoccidioides brasiliensis by ajoene. Antimicrob Agents Chemother (1989) 1.11
Reductive dechlorination of DDE to DDMU in marine sediment microcosms. Science (1998) 1.11
Formation of Fatty Acid-degrading, anaerobic granules by defined species. Appl Environ Microbiol (1996) 1.10
Enhancement of serum-response factor-dependent transcription and DNA binding by the architectural transcription factor HMG-I(Y). J Biol Chem (1998) 1.09
Phospholipase A2 at the bilayer interface. Proteins (1991) 1.09
Comparison of assimilatory organic nitrogen, sulfur, and carbon sources for growth of methanobacterium species. Appl Environ Microbiol (1984) 1.08
Identification of a human cDNA clone for lysosomal type Ca2+-independent phospholipase A2 and properties of the expressed protein. J Biol Chem (1997) 1.08
Measurement of sigma chi c2 B(chi c2-->J/psi gamma)/sigma chi c1 B(chi c1 -->J/psi gamma) in pp collisions at square root s=1.96 TeV. Phys Rev Lett (2007) 1.07
Identification of the phosphorylation sites of cytosolic phospholipase A2 in agonist-stimulated human platelets and HeLa cells. J Biol Chem (1998) 1.06
Design and prototyping of a wristband-type wireless photoplethysmographic device for heart rate variability signal analysis. Conf Proc IEEE Eng Med Biol Soc (2016) 1.05
Cationic peptide antimicrobials induce selective transcription of micF and osmY in Escherichia coli. Biochim Biophys Acta (2000) 1.05
Activation of the beta-galactoside transport system in Escherichia coli ML-308 by n-alkanols. Modification of lipid-protein interaction by a change in bilayer fluidity. Biochim Biophys Acta (1974) 1.05
Ajoene, the antiplatelet principle of garlic, synergistically potentiates the antiaggregatory action of prostacyclin, forskolin, indomethacin and dypiridamole on human platelets. Thromb Res (1986) 1.05
Drug-induced phase change in bilayer as possible mode of action of membrane expanding drugs. Nature (1975) 1.04
Direct measurement of the W production charge asymmetry in pp collisions at square root s=1.96 TeV. Phys Rev Lett (2009) 1.04
Search for long-lived massive charged particles in 1.96 TeV pp collisions. Phys Rev Lett (2009) 1.03
Measurement of d sigma/dM and forward-backward charge asymmetry for high-mass Drell-Yan e(+)e(-) pairs from pp macro collisions at square root of s = 1.8 TeV. Phys Rev Lett (2001) 1.02
Phosphatidylinositol-specific phospholipase C from Bacillus cereus at the lipid-water interface: interfacial binding, catalysis, and activation. Biochemistry (1994) 1.02
Osmotic stress in viable Escherichia coli as the basis for the antibiotic response by polymyxin B. Biochem Biophys Res Commun (1998) 1.01
Interaction of phospholipase A2 and phospholipid bilayers. Biochim Biophys Acta (1982) 1.01
Effect of surgical experience on results of esophagectomy for esophageal carcinoma. J Surg Oncol (1997) 1.00
Trifluoromethyl ketones and methyl fluorophosphonates as inhibitors of group IV and VI phospholipases A(2): structure-function studies with vesicle, micelle, and membrane assays. Biochim Biophys Acta (1999) 1.00
Observation of Bs(0)-Bs(0) oscillations. Phys Rev Lett (2006) 1.00
Fatty acid biosynthesis in yeast. Mol Cell Biochem (1978) 0.99
Do membrane-bound enzymes access their substrates from the membrane or aqueous phase: interfacial versus non-interfacial enzymes. Biochim Biophys Acta (2000) 0.98
Origin of the latency phase during the action of phospholipase A2 on unmodified phosphatidylcholine vesicles. Biochim Biophys Acta (1982) 0.98
Fertility ratio in male rats: effects after denervation of two pelvic floor muscles. Physiol Behav (2000) 0.97
The spontaneous incorporation of proteins into preformed bilayers. Biochim Biophys Acta (1987) 0.97
Search for large extra dimensions in final states containing one photon or jet and large missing transverse energy produced in pp collisions at square root[s]=1.96 TeV. Phys Rev Lett (2008) 0.97
Plasma membrane phosphorylation by endogenous phosphate donors in human blood platelets. Selectivity of the action of dibutyryl cyclic AMP. Biochim Biophys Acta (1976) 0.96
Mitogen-activated protein kinase phosphatase-1 in rat arterial smooth muscle cell proliferation. J Clin Invest (1996) 0.96
Polarizations of J/psi and psi(2S) mesons produced in pp collisions at square root s = 1.96 TeV. Phys Rev Lett (2007) 0.96
Measurement of the top-quark mass in all-hadronic decays in pp collisions at CDF II. Phys Rev Lett (2007) 0.95
Aortic carboxypeptidase-like protein, a novel protein with discoidin and carboxypeptidase-like domains, is up-regulated during vascular smooth muscle cell differentiation. J Biol Chem (1998) 0.95
Tissue section Donovan bodies--identification through slow-Giemsa (overnight) technique. Dermatologica (1987) 0.95
Measurement of the strong coupling constant from inclusive jet production at the Tevatron pp collider. Phys Rev Lett (2002) 0.94
Evidence for direct coupling of primary agonist-receptor interaction to the exposure of functional IIb-IIIa complexes in human blood platelets. Results from studies with the antiplatelet compound ajoene. Biochim Biophys Acta (1991) 0.94
Transcriptome characterization of the dimorphic and pathogenic fungus Paracoccidioides brasiliensis by EST analysis. Yeast (2003) 0.94
Phospholipase A2-catalyzed hydrolysis of vesicles: uses of interfacial catalysis in the scooting mode. Methods Enzymol (1991) 0.94
Isolation of homogeneous phospholipase A2 from human platelets. Biochem Biophys Res Commun (1979) 0.94
Ajoene, the antiplatelet compound derived from garlic, specifically inhibits platelet release reaction by affecting the plasma membrane internal microviscosity. Biochem Pharmacol (1989) 0.94
Effect of ajoene on dimorphism of Paracoccidioides brasiliensis. J Med Vet Mycol (1993) 0.94
Reversible prevention of platelet activation by (E,Z)-4,5,9-trithiadodeca-1,6,11-triene 9-oxide (ajoene) in dogs under extracorporeal circulation. Arzneimittelforschung (1988) 0.93
Studies concerning the possible reconstitution of an active cation pump across an artificial membrane. J Membr Biol (1972) 0.93
Search for gluinos and scalar quarks in pp collisions at square root[s] = 1.8 TeV using the missing energy plus multijets signature. Phys Rev Lett (2002) 0.93
Membrane-bound plasma platelet activating factor acetylhydrolase acts on substrate in the aqueous phase. Biochemistry (1999) 0.93
Human nonpancreatic secreted phospholipase A2: interfacial parameters, substrate specificities, and competitive inhibitors. Biochemistry (1993) 0.92
Familial clustering and genetic heterogeneity in Meniere's disease. Clin Genet (2013) 0.92
Search for a fermiophobic Higgs boson decaying into diphotons in pp[over] collisions at sqrt[s] = 1.96 TeV. Phys Rev Lett (2009) 0.92
Structural basis of the anionic interface preference and kcat* activation of pancreatic phospholipase A2. Biochemistry (2000) 0.91
Phospholipases. I. Effect of n-alkanols on the rate of enzymatic hydrolysis of egg phosphatidylcholine. J Membr Biol (1973) 0.91
Action of phospholipase A2 on bilayers. Effect of inhibitors. Biochim Biophys Acta (1985) 0.91
First measurement of the b-jet cross section in events with a W boson in pp collisions at square root(s) = 1.96 TeV. Phys Rev Lett (2010) 0.91
Kinetics of interfacial catalysis by phospholipase A2 in intravesicle scooting mode, and heterofusion of anionic and zwitterionic vesicles. Biochim Biophys Acta (1986) 0.91
Effects of sterols on permeability and phase transitions of bilayers from phosphatidylcholines lacking acyl groups. Biochemistry (1981) 0.91
Government response to HIV/AIDS in India. AIDS (1994) 0.91
Phospholipase A2 engineering. Structural and functional roles of highly conserved active site residues tyrosine-52 and tyrosine-73. Biochemistry (1992) 0.90